The present study was performed on 75 samples of gastric and colorectal adenocarcinoma blocks. The results showed that most CK7 gastric adenocarcinomas were positive; nevertheless, most CK7 colorectal adenocarcinomas were negative. Moreover, the results of this study showed that there was no statistically significant relationship between prognostic factors (i.e., lymph node involvement, neuronal invasion, and type of tumor differentiation) in both types of cancer.
Previous studies have shown that the expression of CK7 and CK20 can be effective in gastric and colorectal cancers in the diagnosis of pathological tumor metastasis. Furthermore, different expression patterns of CK7 and CK20 in tumors of epithelial origin are useful tools in the differential diagnosis of carcinoma (
7). The CK7 is the cytoplasmic filament of epithelial cells. According to the specific CK profile of cancer, there is a possibility to find the relationship between Ck7 expression and other prognostic factors (
10). Most efforts to express CK7 and CK20 are focused on different metastatic carcinomas to identify their source. However, available data on the association of CK expression patterns with clinicopathological parameters are rare (
11).
According to reports, the most common expression patterns of CK7 and CK20 in colorectal adenocarcinoma are CK20 positive and CK7 negative; nonetheless, the most common expression patterns of CK7 and CK20 in gastric adenocarcinoma are CK20 negative and CK7 positive (
12). Therefore, it can be concluded that the expression patterns of CK7 in gastric and colorectal carcinomas are different and contradictory. In various studies, the expression level of CK7 has been reported within the range of 10 - 75%, which can be due to differences in sample size, grouping, and kit sensitivity. Prognostic factors are used to determine the best treatment management. Previous studies have shown CK7 expression in several colon and gastric adenocarcinomas (
10).
In the present study, it was shown that the incidence of CK7 in gastric cancer was higher in gastric carcinoma with moderate and poor differentiation; however, in colorectal cancer, also the incidence of CK7 was higher in carcinomas with moderate and well differentiation. In general, in the present study, there was no significant relationship between the CK7 expression and degree of tumor differentiation in gastric and colorectal cancers. Park et al. showed that there was no significant relationship between the incidence of CK7 and CK20 and degree of tumor differentiation (
7). Bayrak et al. showed that CK7 expression was higher in tumors with lymph node involvement; nonetheless, CK20 positive was higher in low-grade tumors (
11).
Driessen et al. examined the combined immunohistochemical expression of CK7 and CK20 in 214 resection formalin-fixed paraffin-embedded specimens for adenocarcinoma, including 66 esophageal, 73 cardiac, and 75 distal gastric adenocarcinomas. Their results showed that CK7+/CK20− expression pattern was the most common pattern in tumors situated at the gastroesophageal junction, esophageal, and cardiac adenocarcinomas (67 vs. 68%); however, this cytokeratin pattern was uncommon in distal gastric adenocarcinomas (
13).
Jovanovic et al. showed that CK7 was not observed in the normal mucosa of the large intestine, although it was observed in a few cases with inflamed and damaged mucosa. This marker is observed in all dysplastic cells and has nothing to do with the severity of dysplasia. Additionally, some adenocarcinomas were CK7 positive. Therefore, the colonic dysplasia lesions of the large intestine appear to be CK7 positive (
14).
Gheini et al. (
1) reported a statistically inverse relationship between the incidence of CK20 and CK7 with the degree of tissue differentiation and involvement of lymph nodes in gastric cancer. Although there was a statistically significant relationship between the incidence of tissue invasion in gastric cancer and incidence of CK7, no association was observed between the incidence of CK20 and tissue invasion. Gheini et al. (
1) concluded that a decrease in the expression of CK20 and CK7 was associated with a decrease in tissue differentiation and an increase in lymph node involvement. Previous studies have shown that CK7 expression is of little value in the differential diagnosis of metastatic carcinoma; nevertheless, in some tumors, such as prostate and hepatocellular carcinomas, the absence of cytokeratin is of diagnostic value (
15).
In the present study, no association was observed between lymph node involvement and CK7 expression. Bayrak et al., in a study conducted on 196 samples with colorectal adenocarcinoma, demonstrated a significant association between CK7 positivity and lymph node involvement. This difference may be due to the sample size (
16).
The profile analysis of CK7 and CK20 is one of the methods used to determine the origin of ovarian tumors. If CK7 is positive, it is most likely an ovarian tumor. Some ovarian metastases from adenocarcinoma of the gastric and colon and an increase in the size of these tumors lead to an increase in CK7 expression. Therefore, CK7 expression cannot rule out metastasis in gastrointestinal adenocarcinoma (
10). Additionally, Kummar et al. obtained similar results. They evaluated the negative expression of CK7 in the diagnosis of metastatic lung tumors of the colon. Based on the results, the expression of CK7 could be a sign of lung origin. In the aforementioned study, out of 24 metastatic cases, 2 cases were positive for CK7. Again, given the lack of a large number of these cases, caution should be exercised in dealing with the aforementioned results (
17).
Park et al. showed that all of the 225 cases of metastatic colorectal carcinomas to the ovary were CK7-/CK20+, and only one case was CK7-/CK20-; accordingly, 75% of low-grade and 52% of high-grade carcinomas were CK7-/CK20+ (
7). Gheini et al. demonstrated that CK7-/CK20+ was the most prevalent pattern in colon adenocarcinoma. Furthermore, they reported an insignificant difference in histopathologic grade (P = 0.26), lymph node involvement (P = 0.46), and depth of invasion (P = 0.22) in different CK7/CK20 expression patterns (
18).
Differences in sample size, type of used antibody clone, and type of tumor subtype are among the reasons for the variations in the results of different studies conducted on CK7 expression. The lack of access to complete clinical staging and reduction of the number of samples to comply with the inclusion criteria were the limitations of the present study. Due to the findings of the present study and the small number of performed studies, it is required to perform further studies with a larger sample size and longer follow-up to evaluate the exact effect of this factor on the prognosis.
5.1. Conclusion
The present study showed no association between CK7 expression and prognostic factors in colon and gastric adenocarcinomas. Given these findings and several studies in this field, it is required to perform further studies with a larger sample size to determine the exact prognostic role of this factor.